RECENT-ONSET TYPE 1 DIABETES
Clinical trials for RECENT-ONSET TYPE 1 DIABETES explained in plain language.
Never miss a new study
Get alerted when new RECENT-ONSET TYPE 1 DIABETES trials appear
Sign up with your email to follow new studies for RECENT-ONSET TYPE 1 DIABETES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a shingles vaccine and diabetes drug save insulin cells?
Disease control Not yet recruitingThis study tests whether the shingles vaccine Shingrix and the diabetes drug semaglutide, alone or together, can help preserve the body's ability to make insulin in adults recently diagnosed with type 1 diabetes. The goal is to slow the immune attack on insulin-producing cells an…
Matched conditions: RECENT-ONSET TYPE 1 DIABETES
Phase: PHASE2 • Sponsor: Ministry of Health, Saudi Arabia • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a 3-Step immune therapy save Insulin-Making cells in newly diagnosed type 1 diabetes?
Disease control Not yet recruitingThis early-phase trial tests a three-step immune treatment for people recently diagnosed with Type 1 diabetes (within 6 months). The goal is to preserve the body's remaining insulin production by calming the immune attack and teaching the immune system to tolerate insulin. Sixty …
Matched conditions: RECENT-ONSET TYPE 1 DIABETES
Phase: PHASE1 • Sponsor: Abdullah Kars • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC